ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Extending the benefit of PARP inhibitors through combinations for advanced prostate cancer - Conversation 3"
Episode Synopsis
touchMDT for touchONCOLOGY
Listen to a medical oncologist, a urologist and an oncology pharmacist discuss extending the benefit of PARP inhibitors through combinations for the treatment of advanced prostate cancer.
The multidisciplinary team
Medical Oncologist: Dr Wassim Abida, USA
Urologist: Professor Axel Merseburger, Germany
Oncology Pharmacist: Dr Lisa Holle, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Pfizer. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitor-combinations-in-advanced-prostate-cancer/
Listen to a medical oncologist, a urologist and an oncology pharmacist discuss extending the benefit of PARP inhibitors through combinations for the treatment of advanced prostate cancer.
The multidisciplinary team
Medical Oncologist: Dr Wassim Abida, USA
Urologist: Professor Axel Merseburger, Germany
Oncology Pharmacist: Dr Lisa Holle, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Pfizer. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitor-combinations-in-advanced-prostate-cancer/
In God we trust